Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

You Can't Control Analyst Upgrades and Downgrades, but You Can Control What You Do About Them


Wall Street analysts upgrade and downgrade stocks all the time. You don't need to do anything at all with your portfolio just because one of them adjusts their view about a stock you own or have on your watch list. However, it can make a great deal of sense to find out why they made those changes and factor those points into your investment thesis. Wedbush's recent upgrade of healthcare real estate investment trust (REIT) (NYSE: VTR) is a case in point.

As it turns out, the big upgrade for Ventas was couched against a review of healthcare REIT peer Welltower (NYSE: WELL). While Wedbush didn't change its rating on Welltower, a neutral rating on Wall Street is anything but a ringing endorsement. So, basically, Wedbush decided to push Ventas with an upgrade to outperform Welltower.

Image source: Getty Images.

Continue reading


Source Fool.com

Ventas Inc. Stock

€41.48
1.140%
There is an upward development for Ventas Inc. compared to yesterday, with an increase of -€0.190 (1.140%).
With 9 Buy predictions and only 2 Sell predictions the community sentiment for the stock is positive.
With a target price of 48 € there is a slightly positive potential of 15.72% for Ventas Inc. compared to the current price of 41.48 €.
Like: 0
VTR
Share

Comments